
We are not looking for the next incremental technology company.
We look for large, important markets, whether new or existing, where a durable company needs to be built and no one has built it. That approach has led us to companies:
Making Medicare understandable and actionable for the seniors who depend on it.
Protecting our sovereign assets in space and across emerging defense domains.
Bringing advanced therapies to bear on obesity, diabetes, cardiovascular disease and cancer.
Rebuilding American manufacturing capability from the factory floor up.
On-shoring the pre-clinical, clinical and manufacturing capacity our life sciences companies require.
Reimagining professional services for an era in which the legacy model no longer holds.
Because we invest early and concentrate our capital, we are in the room with our founders for years. Our limited partners include some of the most accomplished investors, entrepreneurs, innovators and institutions in the world.